|
|
|
|
 |
|
SENSEX
|
 |
-19.65
|
-0.08%
|
|
26027.30
|
|
|
|
NIFTY
|
 |
-54.30
|
-0.06%
|
|
85213.36
|
|
|
|
Nasdaq
|
 |
-398.69
|
-1.69%
|
|
23195.17
|
|
|
|
Nikkei 225
|
 |
687.73
|
1.37%
|
|
50836.55
|
|
|
|
FTSE 100
|
 |
-54.17
|
-0.56%
|
|
9649.03
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
540222
|
|
ISIN Demat |
INE947Q01028
|
|
Book Value (Rs) |
91.11
|
|
|
NSE Code |
LAURUSLABS
|
|
Dividend Yield % |
0.12
|
|
Market Cap (Rs) |
542177.97
|
|
|
TTM PE(x) |
79.41
|
|
TTM EPS(Rs) |
12.65
|
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
19-09 2005
|
|
Registered Office
|
Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli, Vishakhapatnam, Andhra Pradesh-531021 .
|
|
ISINNO
|
INE947Q01028
|
|
Phone
|
0891 6821101 / 1102
|
|
E-mail
|
info@lauruslabs.com |
|
URL
|
www.lauruslabs.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Ravindranath Kancherla
|
|
Managing Director
|
|
|
Company Secretary
|
G Venkateswar Reddy
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|